Professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of SurgeryUniversity of Texas, MD Anderson Cancer CenterHouston, Texas, United States
Disclosure information not submitted.
eP812 - A Phase 3, Multicenter, Open-Label, Randomized, Placebo-Controlled Trial, for Ureteral Identification Using Pudexacianinium Chloride (ASP5354) in Patients Undergoing Abdominopelvic Surgery
Monday, June 3, 202410:36 AM – 10:41 AM ET, USA